Costs and Expenses of SOLENO THERAPEUTICS INC from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
SOLENO THERAPEUTICS INC annual and quarterly Costs and Expenses in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • SOLENO THERAPEUTICS INC Costs and Expenses for the quarter ending 30 Sep 2025 was $43,913,000, a 45% decline year-over-year.
  • SOLENO THERAPEUTICS INC annual Costs and Expenses for 2025 was $180,991,000, a 3.6% decline from 2024.
  • SOLENO THERAPEUTICS INC annual Costs and Expenses for 2024 was $187,671,000, a 353% increase from 2023.
Source SEC data
View on sec.gov
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Change (%)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Change (%)

SOLENO THERAPEUTICS INC Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $180,991,000 -$6,680,000 -3.6% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $187,671,000 +$146,287,000 +353% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $41,384,000 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY

SOLENO THERAPEUTICS INC Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $43,913,000 -$36,299,000 -45% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $39,182,000 +$14,314,000 +58% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q3 2024 $80,212,000 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $24,868,000 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.